An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9
Alexander P. Hynes(McMaster University), Sylvain Moineau(The Ohio State University), Dennis Romero(Danone (France)), Marie-Laurence Lemay(Université Laval), Geneviève M. Rousseau(Université Laval), Christophe Fremaux(Danone (France)), Philippe Horvath(International Fund for Agricultural Development)
Cited by 187
Related Papers
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
|Science|2007|6.3k
Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
|Proceedings of the National Academy of Sciences|2012|2.8k
An updated evolutionary classification of CRISPR–Cas systems
|Nature Reviews Microbiology|2015|2.6k
Evolution and classification of the CRISPR–Cas systems
|Nature Reviews Microbiology|2011|2.5k
CRISPR/Cas, the Immune System of Bacteria and Archaea
|Science|2010|2.5k